News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cheng Andrew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 8,868 shares
@ $46.057, valued at
$408.4k
Sold 5,300 shares
@ $46.8836, valued at
$248.5k
Sold 2,662 shares
@ $48.5632, valued at
$129.3k
Sold 1,700 shares
@ $49.7059, valued at
$84.5k
Sold 6,470 shares
@ $50.5619, valued at
$327.1k
Exercised 25,000 options to buy
@ $6.36, valued at
$159k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 13,679 shares
@ $42.8514, valued at
$586.2k
Sold 11,321 shares
@ $43.5211, valued at
$492.7k
Exercised 25,000 options to buy
@ $6.36, valued at
$159k
|
|
| 07/06/2023 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 18,730 shares
@ $44.6606, valued at
$836.5k
Sold 5,051 shares
@ $45.3615, valued at
$229.1k
Sold 1,219 shares
@ $46.2896, valued at
$56.4k
Exercised 25,000 options to buy
@ $6.36, valued at
$159k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 1,613 shares
@ $55.16, valued at
$89k
|
|
| 06/05/2023 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 3,914 shares
@ $44.1752, valued at
$172.9k
Sold 20,686 shares
@ $45.2562, valued at
$936.2k
Sold 400 shares
@ $45.897, valued at
$18.4k
Exercised 21,330 options to buy
@ $0.615, valued at
$13.1k
Exercised 3,670 options to buy
@ $6.36, valued at
$23.3k
|
|
| 05/03/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 21,523 shares
@ $45.0049, valued at
$968.6k
Sold 3,477 shares
@ $45.5045, valued at
$158.2k
Exercised 40,000 options to buy
@ $0.615, valued at
$24.6k
Exercised 25,000 options to buy
@ $0.615, valued at
$15.4k
|
|
| 04/05/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 23,292 shares
@ $37.8783, valued at
$882.3k
Sold 1,708 shares
@ $38.8259, valued at
$66.3k
Exercised 25,000 options to buy
@ $0.615, valued at
$15.4k
|
|
| 04/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/14/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,706 shares
@ $43.47, valued at
$74.2k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 13,200 shares
@ $50.1199, valued at
$661.6k
Sold 3,800 shares
@ $50.8194, valued at
$193.1k
Sold 3,000 shares
@ $52.0319, valued at
$156.1k
Sold 800 shares
@ $53.0878, valued at
$42.5k
Sold 3,900 shares
@ $54.371, valued at
$212k
Sold 300 shares
@ $54.8067, valued at
$16.4k
Exercised 25,000 options to buy
@ $0.615, valued at
$15.4k
|
|
| 12/20/2022 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 87,220 options to buy
@ $21.1, valued at
$1.8M
Exercised 8,500 options to buy
@ $0.615, valued at
$5.2k
|
|
| 12/13/2022 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 52,351 shares
@ $0
Granted 235,580 options to buy
@ $42.95, valued at
$10.1M
|
|
| 12/02/2022 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $46.07, valued at
$460.7k
Exercised 10,000 options to buy
@ $0.615, valued at
$6.2k
|
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 4,550 shares
@ $32.8, valued at
$149.2k
Sold 5,350 shares
@ $33.57, valued at
$179.6k
Sold 100 shares
@ $34.39, valued at
$3.4k
Exercised 10,000 options to buy
@ $0.615, valued at
$6.2k
|
|
| 09/15/2022 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 16,796 shares
@ $26.74, valued at
$449.1k
Sold 43,204 shares
@ $27.69, valued at
$1.2M
Exercised 60,000 options to buy
@ $0.615, valued at
$36.9k
|
|
| 09/13/2022 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 1,152 shares
@ $8.03, valued at
$9.3k
Granted 87,221 options to buy
@ $21.1, valued at
$1.8M
Granted 87,221 options to buy
@ $21.1, valued at
$1.8M
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $19.55, valued at
$195.5k
Exercised 10,000 options to buy
@ $0.615, valued at
$6.2k
|
|
| 01/04/2022 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Exercised 53,000 options to buy
@ $0.615, valued at
$32.6k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 17,500 shares
@ $22.57, valued at
$395k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Cheng Andrew (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Converted 17,488 shares
@ $0
Converted 17,488 preferred shares
@ $0 |
|
|
|
|